“In vitro cytotoxicity analysis on patient-derived PBMCs to predict 6-mercaptopurine therapy response in children with acute lymphoblastic leukemia”, IJBB, vol. 61, no. 6, pp. 371–379, May 2024, doi: 10.56042/ijbb.v61i6.9285.